•
Oct 31, 2012

Summit Therapeutics Q3 2012 Earnings Report

Total Revenue
$643K
Previous year: $899K
-28.5%
EPS
-$0.0905
Previous year: -$0.107
-15.8%
Gross Profit
$249K
Previous year: $351K
-29.1%

Summit Therapeutics

Summit Therapeutics